Perspectives on Use of the Cutaneous Direct Immunofluorescence Assay-Reply

JAMA Dermatol. 2022 Jun 1;158(6):705-706. doi: 10.1001/jamadermatol.2022.1402.

Authors

Julie D R Reimann^{1

2

3

4}, Sean P Moynihan¹, Thomas D Horn^{1

2

3

4}

Affiliations

¹ MGPO Dermatopathology Associates, Newton, Massachusetts.
² Department of Pathology, Massachusetts General Hospital, Boston.
³ Department of Dermatology, Massachusetts General Hospital, Boston.
⁴ Harvard Medical School, Boston, Massachusetts.

PMID: 35544040
DOI: 10.1001/jamadermatol.2022.1402

No abstract available

Publication types

Comment

MeSH terms

Administration, Cutaneous
Fluorescent Antibody Technique, Direct
Humans
Skin*